Related references
Note: Only part of the references are listed.Molecular Insights into Site-Specific Interferon-α2a Bioconjugates Originated from PEG, LPG, and PEtOx
Niklas Hauptstein et al.
BIOMACROMOLECULES (2021)
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
Phillip D. Monk et al.
LANCET RESPIRATORY MEDICINE (2021)
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Stephan Urban et al.
GUT (2021)
Cysteine-specific protein multi-functionalization and disulfide bridging using 3-bromo-5-methylene pyrrolones
Yingqian Zhang et al.
NATURE COMMUNICATIONS (2020)
COVID-19: lambda interferon against viral load and hyperinflammation
Evangelos Andreakos et al.
EMBO MOLECULAR MEDICINE (2020)
Biodistribution of Site-Specific PEGylated Fibroblast Growth Factor-2
Tessa Luehmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Structural basis of serum albumin recognition by SL335, an antibody Fab extending the serum half-life of protein therapeutics
So Yeon Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
Jeong Seok Lee et al.
SCIENCE IMMUNOLOGY (2020)
ARX788, a Site-specific Anti-HER2 Antibody-Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1-resistant Breast and Gastric Cancers
Lillian Skidmore et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
Yi-Wen Huang et al.
HEPATOLOGY INTERNATIONAL (2020)
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
Megan L. Stanifer et al.
CELL REPORTS (2020)
Roles of IFN-γ in tumor progression and regression: a review
Dragica Jorgovanovic et al.
BIOMARKER RESEARCH (2020)
The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
Alexey A. Lozhkov et al.
PATHOGENS (2020)
Gene expression in chronic granulomatous disease and interferon-γ receptor-deficient cells treated in vitro with interferon-γ
Josias B. Frazao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β
Soo-In Ji et al.
IMMUNOLOGY LETTERS (2019)
Translational Control using an Expanded Genetic Code
Yusuke Kato
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Differential Regulation of Type I and Type III Interferon Signaling
Megan L. Stanifer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Structure of the IFNγ receptor complex guides design of biased agonists
Juan L. Mendoza et al.
NATURE (2019)
Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection
Courtney E. Comar et al.
MBIO (2019)
Decoding type I and III interferon signalling during viral infection
Emily Mesev et al.
NATURE MICROBIOLOGY (2019)
Thermoresponsive and Protease-Cleavable Interferon-Polypeptide Conjugates with Spatiotemporally Programmed Two-Step Release Kinetics for Tumor Therapy
Zhuoran Wang et al.
ADVANCED SCIENCE (2019)
Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection
Xuan Feng et al.
EBIOMEDICINE (2019)
Site-selective protein conjugation at histidine
Karolina Peciak et al.
CHEMICAL SCIENCE (2019)
One-month zero-order sustained release and tumor eradication after a single subcutaneous injection of interferon alpha fused with a body-temperature-responsive polypeptide
Zhuoran Wang et al.
BIOMATERIALS SCIENCE (2019)
BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN THE FIRST INTERIM ANALYSIS OF THE PEGINTERFERON BETA-1A TREATMENT IN THE PHASE 4 PLEGRIDY OBSERVATIONAL PROGRAM (POP)
Marco Salvetti et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Site-Specific Conjugated Insulin-like Growth Factor-I for Anabolic Therapy
Fang Wu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flavia Castro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Site-Specific Conjugated Insulin-like Growth Factor-I for Anabolic Therapy
Fang Wu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
The Dual Nature of Type I and Type II Interferons
Amanda J. Lee et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
Ioanna E. Galani et al.
IMMUNITY (2017)
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
Juan L. Mendoza et al.
IMMUNITY (2017)
Expanding and reprogramming the genetic code
Jason W. Chin
NATURE (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Type I Interferon in Chronic Virus Infection and Cancer
Laura M. Snell et al.
TRENDS IN IMMUNOLOGY (2017)
Targeting fibronectin for cancer imaging and therapy
Zheng Han et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract
Evangelos Andreakos et al.
FRONTIERS IN IMMUNOLOGY (2017)
Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
Ivan Zanoni et al.
FRONTIERS IN IMMUNOLOGY (2017)
Type I interferons as Regulators of Lung inflammation
Spyridon Makris et al.
FRONTIERS IN IMMUNOLOGY (2017)
Peg-interferon lambda Treatment induces robust innate and adaptive immunity in chronic hepatitis B Patients
Sandra Phillips et al.
FRONTIERS IN IMMUNOLOGY (2017)
IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function
Achille Broggi et al.
NATURE IMMUNOLOGY (2017)
Type III interferon is a critical regulator of innate antifungal immunity
Vanessa Espinosa et al.
SCIENCE IMMUNOLOGY (2017)
Site-Directed Immobilization of BMP-2: Two Approaches for the Production of Innovative Osteoinductive Scaffolds
Barbara Tabisz et al.
BIOMACROMOLECULES (2017)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Interleukin-4-Clicked Surfaces Drive M2 Macrophage Polarization
Tessa Luehmann et al.
CHEMBIOCHEM (2016)
IFN is a potent anti-influenza therapeutic without the inflammatory side effects of IFN treatment
Sophia Davidson et al.
EMBO MOLECULAR MEDICINE (2016)
Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines
Jordan Despanie et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Generation of influenza A viruses as live but replication-incompetent virus vaccines
Longlong Si et al.
SCIENCE (2016)
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
Georg Wandrey et al.
JOURNAL OF BIOLOGICAL ENGINEERING (2016)
Viral Evasion Strategies in Type I IFN Signaling - A Summary of Recent Developments
Katharina S. Schulz et al.
FRONTIERS IN IMMUNOLOGY (2016)
Enhancing Pharmacokinetics, Tumor Accumulation, and Antitumor Efficacy by Elastin-Like Polypeptide Fusion of Interferon Alpha
Jin Hu et al.
ADVANCED MATERIALS (2015)
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry
Michael P. VanBrunt et al.
BIOCONJUGATE CHEMISTRY (2015)
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
Heinz Gisslinger et al.
BLOOD (2015)
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
K. Abiko et al.
BRITISH JOURNAL OF CANCER (2015)
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
Seiichi Sato et al.
IMMUNITY (2015)
Optimal PEGylation can Improve the Exposure of Interferon in the Lungs Following Pulmonary Administration
Victoria M. Mcleod et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Leukocyte-Derived IFN-α/β and Epithelial IFN-λ Constitute a Compartmentalized Mucosal Defense System that Restricts Enteric Virus Infections
Tanel Mahlakoiv et al.
PLOS PATHOGENS (2015)
Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation
Tessa Luehmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation
Tessa Luehmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Pharmacokinetics, Pharmacodynamics, and Safety of Peginterferon Beta-1a in Subjects with Normal or Impaired Renal Function
Xiao Hu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Expanding and Reprogramming the Genetic Code of Cells and Animals
Jason W. Chin
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo
Meng Li et al.
CANCER CELL INTERNATIONAL (2014)
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J. Muir et al.
JOURNAL OF HEPATOLOGY (2014)
How Type I Interferons Work in Multiple Sclerosis and Other Diseases: Some Unexpected Mechanisms
Anthony T. Reder et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
A general approach to site-specific antibody drug conjugates
Feng Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Prevention of adverse events of interferon γ gene therapy by gene delivery of interferon γ-heparin-binding domain fusion protein in mice
Mitsuru Ando et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Recruiting Cytotoxic T Cells to Folate-Receptor-Positive Cancer Cells
Sumith A. Kularatne et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Anti-CD20-Interferon-β Fusion Protein Therapy of Murine B-Cell Lymphomas
Kham R. Trinh et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Characterization and quantitation of aggregates and particles in interferon- products: Potential links between product quality attributes and immunogenicity
James G. Barnard et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Computational Design of an Unnatural Amino Acid Dependent Metalloprotein with Atomic Level Accuracy
Jeremy H. Mills et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
G. R. Foster et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
Jacob Piehler et al.
IMMUNOLOGICAL REVIEWS (2012)
PEGylated PRINT Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics
Jillian L. Perry et al.
NANO LETTERS (2012)
Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy
Raquel Mejias et al.
BIOMATERIALS (2011)
Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Christoph Thomas et al.
CELL (2011)
Direct Effects of Type I Interferons on Cells of the Immune System
Sandra Hervas-Stubbs et al.
CLINICAL CANCER RESEARCH (2011)
Binding and activity of all human alpha interferon subtypes
Thomas B. Lavoie et al.
CYTOKINE (2011)
Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation
Katharina Frey et al.
INTEGRATIVE BIOLOGY (2011)
Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis
Dana Briesemeister et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Adding New Chemistries to the Genetic Code
Chang C. Liu et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1
Stefan Zeuzem et al.
GASTROENTEROLOGY (2010)
Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection
Andrew J. Muir et al.
HEPATOLOGY (2010)
Expanding the Genetic Code of Yeast for Incorporation of Diverse Unnatural Amino Acids via a Pyrrolysyl-tRNA Synthetase/tRNA Pair
Susan M. Hancock et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections
Markus Mordstein et al.
JOURNAL OF VIROLOGY (2010)
Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection
Megan T. Baldridge et al.
NATURE (2010)
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
Jonathan R. Brody et al.
CELL CYCLE (2009)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Albinterferon α-2b:: a genetic fusion protein for the treatment of chronic hepatitis C
G. Mani Subramanian et al.
NATURE BIOTECHNOLOGY (2007)
Interferon-beta - Mechanism of action and dosing issues
Clyde E. Markowitz
NEUROLOGY (2007)
Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor
DH Doherty et al.
BIOCONJUGATE CHEMISTRY (2005)
Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy
C Ebbinghaus et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation
MS Rosendahl et al.
BIOCONJUGATE CHEMISTRY (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions
JA Langer et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
The development of a modified human IFN-α2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection
TD Jones et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Site-specific PEGylation of proteins containing unnatural amino acids
A Deiters et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Genetically engineered silk-elastinlike protein polymers for controlled drug delivery
Z Megeed et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Single-dose pharmacokinetics and safety of pegylated interferon-α2b in patients with chronic renal dysfunction
SK Gupta et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Use of peginterferon a1fa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
KR Reddy et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications
YS Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C
P Bailon et al.
BIOCONJUGATE CHEMISTRY (2001)
Pegylated interferon-α2b:: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
P Glue et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Identification of the major positional isomer of pegylated interferon alpha-2b
YS Wang et al.
BIOCHEMISTRY (2000)
A new functional suppressor tRNA/aminoacyl-tRNA synthetase pair for the in vivo incorporation of unnatural amino acids into proteins
L Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
A novel transcription factor, T-bet, directs Th1 lineage commitment
SJ Szabo et al.
CELL (2000)
Share Paper
